U.S. Food and Drug Administration
of Center for Drug Evaluation and Research
FDA Statement on the Results
of the Women's Health Initiative (8/13/2002) Women's Health Initiative
(WHI) Results.
Signal Need for Reassessment of Risks
and Benefits of Conjugated Equine Estrogens/medroxyprogesterone
Acetate (Prempro) in Postmenopausal Women. |